Logo - P&S Intelligence
  • Home
  • Report Store
    • Report Store
      • Consumer Products
      • Life Sciences
      • ICT and Media
      • Semiconductor and Electronics
      • Chemicals and Materials
      • Automotive and Transportation
      • Power and Energy
      • Heating & Cooling
      • Aerospace & Defense
      • Construction & Heavy Machinery
    • Back
  • Services
  • Knowledge Center
    • Knowledge Center
      • Press Journals
      • Blogs
      • Case Studies
    • Back
  • About Us
  • Contact Us
In Vitro Diagnostic (IVD) Market

Report Code:  10210  |  Available Format: PDF  |  Pages:  344

  • Get Free Sample
  • Make an Inquiry
  • Home
  • Life Sciences
  • In Vitro Diagnostic (IVD) Market

In Vitro Diagnostic (IVD) Market Research Report: By Offering (Reagents & Kits, Instruments, Software & Services), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology, Microbiology), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases), End User (Hospitals & Clinics, Point of Care, Laboratories, Research & Academic Institutes) - Global Industry Analysis and Growth Forecast to 2030

  • Report Code: 10210
  • Available Format: PDF
  • Pages: 344
  • Report Description
  • Table of Contents
  • Market Segmentation
  • Request Free Sample

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Offering

1.3.2 Market Segmentation by Technology

1.3.3 Market Segmentation by Application

1.3.4 Market Segmentation by End User

1.3.5 Market Segmentation by Region

1.3.6 Analysis Period

1.3.7 Market Data Reporting Unit

1.3.7.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Offering

4.1.1.1 Reagents & kits

4.1.1.2 Instruments

4.1.1.3 Software & services

4.1.2 By Technology

4.1.2.1 Clinical chemistry

4.1.2.1.1 Basic metabolic panel

4.1.2.1.2 Lipid profile

4.1.2.1.3 Liver profile

4.1.2.1.4 Renal profile

4.1.2.1.5 Thyroid function panel

4.1.2.1.6 Others

4.1.2.2 Immunochemistry

4.1.2.2.1 ELISA

4.1.2.2.2 RIA

4.1.2.2.3 FIA

4.1.2.2.4 CLIA

4.1.2.2.5 ICA

4.1.2.2.6 Others

4.1.2.3 Molecular diagnostics

4.1.2.3.1 Infectious diseases

4.1.2.3.2 Genomics

4.1.2.3.3 Blood donor screening

4.1.2.3.4 Others

4.1.2.4 Hematology

4.1.2.4.1 CBC

4.1.2.4.2 Cholesterol testing

4.1.2.4.3 Blood glucose testing

4.1.2.4.4 Hemoglobin testing

4.1.2.4.5 Coagulation testing

4.1.2.4.6 Others

4.1.2.5 Others

4.1.3 By Application

4.1.3.1 Infectious diseases

4.1.3.2 Diabetes

4.1.3.3 Oncology

4.1.3.4 Cardiology

4.1.3.5 Nephrology

4.1.3.6 Autoimmune diseases

4.1.3.7 Others

4.1.4 By End User

4.1.4.1 Hospitals & clinics

4.1.4.2 POC

4.1.4.3 Research & academic institutes

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Approval and launch of new products

4.2.1.2 Increasing number of collaborations and agreements

4.2.2 Drivers

4.2.2.1 Regulations with respect to blood safety and sample contamination

4.2.2.2 Surging burden of chronic diseases

4.2.2.3 Increasing number of blood donors

4.2.2.4 Advancements in IVD technology

4.2.2.5 Increasing healthcare expenditure

4.2.2.6 Increasing number of hospitals and academic institutes

4.2.2.7 Impact analysis of drivers on the market forecast period

4.2.3 Restraints

4.2.3.1 Challenges in maintaining sufficient, safe sample supply

4.2.3.2 Data insecurity over donors’ demographic information

4.2.3.3 Cost-ineffectiveness of IVD products

4.2.3.4 Impact analysis of restraints on the market forecast

4.3 Porter’s Five Forces Analysis

4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast

5.1 By Offering

5.2 By Technology

5.2.1 IVD Market for Clinical Chemistry, by Type

5.2.2 IVD Market for Immunochemistry, by Type

5.2.3 IVD Market for Molecular Diagnostics, by Type

5.2.4 IVD Market for Hematology, by Type

5.3 By Application

5.4 By End User

5.5 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Offering

6.2 By Technology

6.2.1 IVD Market for Clinical Chemistry, by Type

6.2.2 IVD Market for Immunochemistry, by Type

6.2.3 IVD Market for Molecular Diagnostics, by Type

6.2.4 IVD Market for Hematology, by Type

6.3 By Application

6.4 By End User

6.5 By Country

6.5.1 U.S. Market Size and Forecast

6.5.1.1 By offering

6.5.1.2 By technology

6.5.1.2.1 IVD market for clinical chemistry, by type

6.5.1.2.2 IVD market for immunochemistry, by type

6.5.1.2.3 IVD market for molecular diagnostics, by type

6.5.1.2.4 IVD market for hematology, by type

6.5.1.3 By application

6.5.1.4 By end user

6.5.2 Canada Market Size and Forecast

6.5.2.1 By offering

6.5.2.2 By technology

6.5.2.2.1 IVD market for clinical chemistry, by type

6.5.2.2.2 IVD market for immunochemistry, by type

6.5.2.2.3 IVD market for molecular diagnostics, by type

6.5.2.2.4 IVD market for hematology, by type

6.5.2.3 By application

6.5.2.4 By end user

Chapter 7. Europe Market Size and Forecast

7.1 By Offering

7.2 By Technology

7.2.1 IVD Market for Clinical Chemistry, by Type

7.2.2 IVD Market for Immunochemistry, by Type

7.2.3 IVD Market for Molecular Diagnostics, by Type

7.2.4 IVD Market for Hematology, by Type

7.3 By Application

7.4 By End User

7.5 By Country

7.5.1 Germany Market Size and Forecast

7.5.1.1 By offering

7.5.1.2 By technology

7.5.1.2.1 IVD market for clinical chemistry, by type

7.5.1.2.2 IVD market for immunochemistry, by type

7.5.1.2.3 IVD market for molecular diagnostics, by type

7.5.1.2.4 IVD market for hematology, by type

7.5.1.3 By application

7.5.1.4 By end user

7.5.2 France Market Size and Forecast

7.5.2.1 By offering

7.5.2.2 By technology

7.5.2.2.1 IVD market for clinical chemistry, by type

7.5.2.2.2 IVD market for immunochemistry, by type

7.5.2.2.3 IVD market for molecular diagnostics, by type

7.5.2.2.4 IVD market for hematology, by type

7.5.2.3 By application

7.5.2.4 By end user

7.5.3 Italy Market Size and Forecast

7.5.3.1 By offering

7.5.3.2 By technology

7.5.3.2.1 IVD market for clinical chemistry, by type

7.5.3.2.2 IVD market for immunochemistry, by type

7.5.3.2.3 IVD market for molecular diagnostics, by type

7.5.3.2.4 IVD market for hematology, by type

7.5.3.3 By application

7.5.3.4 By end user

7.5.4 Spain Market Size and Forecast

7.5.4.1 By offering

7.5.4.2 By technology

7.5.4.2.1 IVD market for clinical chemistry, by type

7.5.4.2.2 IVD market for immunochemistry, by type

7.5.4.2.3 IVD market for molecular diagnostics, by type

7.5.4.2.4 IVD market for hematology, by type

7.5.4.3 By application

7.5.4.4 By end user

7.5.5 U.K. Market Size and Forecast

7.5.5.1 By offering

7.5.5.2 By technology

7.5.5.2.1 IVD market for clinical chemistry, by type

7.5.5.2.2 IVD market for immunochemistry, by type

7.5.5.2.3 IVD market for molecular diagnostics, by type

7.5.5.2.4 IVD market for hematology, by type

7.5.5.3 By application

7.5.5.4 By end user

Chapter 8. APAC Market Size and Forecast

8.1 By offering

8.2 By Technology

8.2.1 IVD Market for Clinical Chemistry, by Type

8.2.2 IVD Market for Immunochemistry, by Type

8.2.3 IVD Market for Molecular Diagnostics, by Type

8.2.4 IVD Market for Hematology, by Type

8.3 By Application

8.4 By End User

8.5 By Country

8.5.1 China Market Size and Forecast

8.5.1.1 By offering

8.5.1.2 By technology

8.5.1.2.1 IVD market for clinical chemistry, by type

8.5.1.2.2 IVD market for immunochemistry, by type

8.5.1.2.3 IVD market for molecular diagnostics, by type

8.5.1.2.4 IVD market for hematology, by type

8.5.1.3 By application

8.5.1.4 By end user

8.5.2 Japan Market Size and Forecast

8.5.2.1 By offering

8.5.2.2 By technology

8.5.2.2.1 IVD market for clinical chemistry, by type

8.5.2.2.2 IVD market for immunochemistry, by type

8.5.2.2.3 IVD market for molecular diagnostics, by type

8.5.2.2.4 IVD market for hematology, by type

8.5.2.3 By application

8.5.2.4 By end user

8.5.3 India Market Size and Forecast

8.5.3.1 By offering

8.5.3.2 By technology

8.5.3.2.1 IVD market for clinical chemistry, by type

8.5.3.2.2 IVD market for immunochemistry, by type

8.5.3.2.3 IVD market for molecular diagnostics, by type

8.5.3.2.4 IVD market for hematology, by type

8.5.3.3 By application

8.5.3.4 By end user

Chapter 9. LATAM Market Size and Forecast

9.1 By offering

9.2 By Technology

9.2.1 IVD Market for Clinical Chemistry, by Type

9.2.2 IVD Market for Immunochemistry, by Type

9.2.3 IVD Market for Molecular Diagnostics, by Type

9.2.4 IVD Market for Hematology, by Type

9.3 By Application

9.4 By End User

9.5 By Country

9.5.1 Brazil Market Size and Forecast

9.5.1.1 By offering

9.5.1.2 By technology

9.5.1.2.1 IVD market for clinical chemistry, by type

9.5.1.2.2 IVD market for immunochemistry, by type

9.5.1.2.3 IVD market for molecular diagnostics, by type

9.5.1.2.4 IVD market for hematology, by type

9.5.1.3 By application

9.5.1.4 By end user

9.5.2 Mexico Market Size and Forecast

9.5.2.1 By offering

9.5.2.2 By technology

9.5.2.2.1 IVD market for clinical chemistry, by type

9.5.2.2.2 IVD market for immunochemistry, by type

9.5.2.2.3 IVD market for molecular diagnostics, by type

9.5.2.2.4 IVD market for hematology, by type

9.5.2.3 By application

9.5.2.4 By end user

Chapter 10. MEA Market Size and Forecast

10.1 By offering

10.2 By Technology

10.2.1 IVD Market for Clinical Chemistry, by Type

10.2.2 IVD Market for Immunochemistry, by Type

10.2.3 IVD Market for Molecular Diagnostics, by Type

10.2.4 IVD Market for Hematology, by Type

10.3 By Application

10.4 By End User

10.5 By Country

10.5.1 Saudi Arabia Market Size and Forecast

10.5.1.1 By offering

10.5.1.2 By technology

10.5.1.2.1 IVD market for clinical chemistry, by type

10.5.1.2.2 IVD market for immunochemistry, by type

10.5.1.2.3 IVD market for molecular diagnostics, by type

10.5.1.2.4 IVD market for hematology, by type

10.5.1.3 By application

10.5.1.4 By end user

10.5.2 South Africa Market Size and Forecast

10.5.2.1 By offering

10.5.2.2 By technology

10.5.2.2.1 IVD market for clinical chemistry, by type

10.5.2.2.2 IVD market for immunochemistry, by type

10.5.2.2.3 IVD market for molecular diagnostics, by type

10.5.2.2.4 IVD market for hematology, by type

10.5.2.3 By application

10.5.2.4 By end user

Chapter 11. Competitive Landscape

11.1 Global IVD Market Share of Key Players

11.2 Strategic Developments of Key Players

11.2.1 Product Launches and Approvals

11.2.2 Mergers and Acquisitions

11.2.3 Other Developments

Chapter 12. Company Profiles

12.1 Thermo Fisher Scientific Inc.

12.1.1 Business Overview

12.1.2 Product and Service Offerings

12.1.3 Key Financial Summary

12.2 Danaher Corporation

12.2.1 Business Overview

12.2.2 Product and Service Offerings

12.2.3 Key Financial Summary

12.3 F. Hoffmann-La Roche Ltd.

12.3.1 Business Overview

12.3.2 Product and Service Offerings

12.3.3 Key Financial Summary

12.4 PerkinElmer Inc.

12.4.1 Business Overview

12.4.2 Product and Service Offerings

12.4.3 Key Financial Summary

12.5 Quidel Corporation

12.5.1 Business Overview

12.5.2 Product and Service Offerings

12.5.3 Key Financial Summary

12.6 OraSure Technologies Inc.

12.6.1 Business Overview

12.6.2 Product and Service Offerings

12.6.3 Key Financial Summary

Place An Order

USD 4900 USD 6400 USD 8400
  • INQUIRE BEFORE PURCHASE
Connect with our sales team
  • International:+1-347-960-6455
  • US/Canada Toll Free:+1-888-778-7886
  • [email protected]
Customized Report Solution

Get a bespoke market intelligence solution

  • Buy report sections that meet your requirements
  • Get the report customized as per your needs
  • Request Customized Report
Our Client Partners
Client
Share this report

Want a report tailored exactly to your business strategy?

Request Customization

Want an insight-rich discussion with the report author?

Speak to Analyst
 
We are committed to ensuring the highest level of client satisfaction
Quality Acknowledgement
Quality Acknowledgement

Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you

Unmatched Standards
Unmatched Standards

Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights

Reach Us
Reach Us Whenever You Need

With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required

Data Security
Complete Data Security

We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws

  • Make An Enquiry
  • Request Free Sample

Connect with us
Quick Links
  • Research Methodology
  • Career
  • Media Citations
  • FAQs
  • Events and Conferences
Find Help
  • How to Order
  • Privacy Policy
  • Terms & Conditions
  • Sitemap
24/7 Customer Support
  • International: +1-347-960-6455
  • US/Canada Toll Free: +1-888-778-7886
  • India: +91-120-454-1337
  • For business enquiries - [email protected]
  • For career enquiries - [email protected]
  • Dun-Verified
  • Paypal-Secure

©2025 P&S Intelligence. All Rights Reserved.

We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. Privacy Policy X